ChemicalBook >> CAS DataBase List >>CI 15511

CI 15511

CAS No.
131-28-2
Chemical Name:
CI 15511
Synonyms
NARCEINE;NARCEIN;CI 15511;NIH 10760;henyl)acetyl)-;CI 15511,Narceine;Narceine (base and/or unspecified salts);4-(methylenedioxy)phenyl)acetyl)-6-((6-(2-(dimethylamino)ethyl)-2-methoxy-;o-veratricacid,6-((6-(2-(dimethylamino)ethyl)-2-methoxy-3,4-(methylenedioxy)p;4-[2-(2-Hydroxy-1-naphtyl)-2-sodiosulfohydrazino]benzenesulfonic acid sodium salt
CBNumber:
CB0445649
Molecular Formula:
C23H27NO8
Molecular Weight:
445.46
MDL Number:
MFCD00064903
MOL File:
131-28-2.mol
Last updated:2025-04-17 18:22:24

CI 15511 Properties

Melting point 138°; mp 176°
Boiling point 555.14°C (rough estimate)
Density 1.3285 (rough estimate)
refractive index 1.5614 (estimate)
pka pKb (20°) = 10.7, pKa = 9.3
Water Solubility 579.1mg/L(15 ºC)
CAS DataBase Reference 131-28-2
FDA UNII CTT09X2F1M

CI 15511 price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 45067 Narceine ≥98% 131-28-2 1mg $72 2026-04-30 Buy
Cayman Chemical 45067 Narceine ≥98% 131-28-2 5mg $288 2026-04-30 Buy
ChemScene CS-0026319 Narceine 131-28-2 5mg $135 2026-06-04 Buy
ChemScene CS-0026319 Narceine 131-28-2 10mg $217 2026-06-04 Buy
ChemScene CS-0026319 Narceine 131-28-2 25mg $433 2026-06-04 Buy
Product number Packaging Price Buy
45067 1mg $72 Buy
45067 5mg $288 Buy
CS-0026319 5mg $135 Buy
CS-0026319 10mg $217 Buy
CS-0026319 25mg $433 Buy

CI 15511 Chemical Properties,Uses,Production

Description

An alkaloid of opium (Papaver somniferum) was first isolated by Pelletier in 1832 but not characterized until some years later by Couerbe and Anderson, the latter assigning to it the formula C23H2909N which was accepted until Freund showed that it contains H20 of crystallization. The base remains in the mother liquors after removal of the major alkaloids. It forms slender, colourless needles or prisms of the trihydrate, m.p. 170°C. It is optically inactive and dissolves readily in alkalies forming metallic derivatives. It behaves as a weak, monoacidic base forming well-crystallized salts. The hydrochloride crystallizes with 5.5 H20 from cold, dilute HCI, or as the trihydrate from hot solutions. From MeOH it yields crystals with 1 mole of solvent, m.p. 190-2°C. The aurichloride forms reddish-yellow needles, m.p. 130°C and the picrate has m.p. 195°C. With chlorine water, followed by the addition of ammonia, it gives a characteristic blood-red colour while with dilute iodine solution, the solid alkaloid develops a blue colour. With ethyl nitrite, narceine forms an oximino derivative which, on exhaustive methylation, furnishes trimethylamine, hemipinic acid and 2-cyano-3- methoxy-4: s-methylenedioxy-1-vinylbenzene.

Uses

Narceine (Narcein), a quinolone derivative, is an opium alkaloid with anti-diabetic property[1][2].

Definition

ChEBI: Narceine is a stilbenoid.

Purification Methods

Recrystallise Narcein from water (as trihydrate). The styphnate has m 185-189o (from EtOH), and the picrate has m 200o (from EtOH). [Beilstein 19 H 370, 19 I 797, 19 II 386, 19 IV 4382.]

References

Couerbe., Annalen, 17,171 (1836)
Anderson., ibid, 86, 182 (1853)
Roser., ibid, 247, 167 (1888)
Freund, Frankforter., ibid, 277,20 (1893)
Freund, Oppenheimer., Ber., 42, 1084 (1909)

CI 15511 Preparation Products And Raw materials

Raw materials

Preparation Products

CI 15511 Suppliers

Global( 14)Suppliers
Supplier Tel Email Country ProdList Advantage
Beijing Yisiyan Technology Research Center 010-56645598 13366904824; bjkaida@163.com China 1596 59
ShangHai Caerulum Pharma Discovery Co., Ltd. 18149758185 18149758185 sales-cpd@caerulumpharma.com China 3493 58
Jinan Ruisi Pharmaceutical Technology Co., LTD 0531-0531-69900633 19963472814 changyuan20@163.com China 9937 58
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. 025-025-66113011 15955137747 cb5@aikonchem.com China 10354 58
Alchem Pharmtech,Inc. 8485655694 sales@alchempharmtech.com United States 63645 58
CI 15511 NARCEIN 4-(methylenedioxy)phenyl)acetyl)-6-((6-(2-(dimethylamino)ethyl)-2-methoxy- henyl)acetyl)- o-veratricacid,6-((6-(2-(dimethylamino)ethyl)-2-methoxy-3,4-(methylenedioxy)p 6-((6-(2-(Dimethylamino)ethyl)-2-methoxy-3,4-(methylenedioxy)phenyl)ac etyl)-o-veratric acid Narceine (base and/or unspecified salts) 6-[[6-[2-(Dimethylamino)ethyl]-4-methoxy-1,3-benzodioxol-5-yl]acetyl]-2,3-dimethoxybenzoic acid 4-[2-(2-Hydroxy-1-naphtyl)-2-sodiosulfohydrazino]benzenesulfonic acid sodium salt 6-[2-[6-(2-dimethylaminoethyl)-4-methoxy-1,3-benzodioxol-5-yl]acetyl]-2,3-dimethoxybenzoic acid 6-[2-[6-(2-dimethylaminoethyl)-4-methoxy-1,3-benzodioxol-5-yl]acetyl]-2,3-dimethoxy-benzoic acid 6-[2-[6-(2-dimethylaminoethyl)-4-methoxy-1,3-benzodioxol-5-yl]ethanoyl]-2,3-dimethoxy-benzoic acid NIH 10760 6-(2-(6-(2-(Dimethylamino)ethyl)-4-methoxybenzo[d][1,3]dioxol-5-yl)acetyl)-2,3-dimethoxybenzoic acid Benzoic acid, 6-[2-[6-[2-(dimethylamino)ethyl]-4-methoxy-1,3-benzodioxol-5-yl]acetyl]-2,3-dimethoxy- 6-[2-[6-[2-(dimethylamino)ethyl]-4-methoxy-1,3-benzodioxol-5-yl]acetyl]-2,3-dimethoxybenzoicaci CI 15511,Narceine NARCEINE 131-28-2 C23H27NO8